• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Long-awaited report outlines how to fight antimicrobial resistance—and how to pay for it

Gert van der Hoek

In Memoriam - Editor, Senior Moderator
May 18, 2016

Food producers should label meat to reflect the quantity of antibiotics used in producing it. Pharmaceutical companies should receive a $1 billion windfall for developing a drug effective against particularly dangerous resistant pathogens. And a massive global campaign should be launched to make the world more aware of the dangers of antimicrobial resistance (AMR). These are just three conclusions from a widely anticipated report on how to tackle the spread of antimicrobial resistance, which was published today. Commissioned in 2014 by U.K. Prime Minister David Cameron and the Wellcome Trust, the report was led by economist Jim O’Neill, currently the Commercial Secretary to the Treasury in the United Kingdom.

Using antimicrobial drugs (not just antibiotics but also drugs against fungal, viral, or parasitic infections) invariably leads to the spread of pathogens that can tolerate them, and the problem is reaching crisis proportions, health experts widely agree. More and more pathogens are becoming resistant even to drugs seen as the last line of defense. Already, an estimated 700,000 people die every year from drug-resistant infections. (It’s important to note, however, that this estimate includes many who would have died even if their infection had been susceptible.) By 2050, drug-resistant infections could kill more people than cancer, according to the new report.

The experts call for a two-tiered approach: Lower the use of available antimicrobials and increase the supply by stimulating the development of new ones. For instance, improved hygiene, faster and better diagnostics, and new vaccines could reduce unnecessary use of antibiotics. The authors also advocate a worldwide campaign to educate people about the dangers of resistance to keep patients from demanding antimicrobial drugs and doctors from prescribing them—an idea Laxminarayan endorses.

LINK TO FULL ARTICLE
 
England’s chief medical officer warns of ‘antibiotic apocalypse’

Efficiency of antibiotics falling as deaths in EU and US hit around 50,000 annually from infections drugs can no longer treat

Thursday 19 May 2016 00.01 BST


The “antibiotic apocalypse” may already be upon us. According to Dame Sally Davies, chief medical officer for England, 50,000 people are dying every year in Europe and the US from infections that antibiotics have lost the power to treat.

Davies has been at the forefront of the UK’s efforts against antimicrobial resistance (AMR) and taken on a global leadership role. She has described the threatened loss of antibiotics to the world as on a par with terrorism and climate change.

As the final report of Jim O’Neill, the economist charged by the prime minister with finding solutions to the crisis, was published, Davies warned that the death toll was already high and our life spans, which once seemed to be forever lengthening, may fall.

“We are already seeing the consequences of AMR, with estimates of around 50,000 deaths per year recently in Europe and the US, due to antibiotic resistant infections, and far greater numbers worldwide,” Davies wrote in the foreword to a report by the Institute and Faculty of Actuaries on antimicrobial resistance.


“The projected figures are much more worrying. It is quite possible – and perhaps even likely – that the recent era of material mortality improvements will give way to many years of material mortality worsening.”

READ MORE
 
Back
Top